These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 23095751)

  • 1. The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.
    de la Parra C; Otero-Franqui E; Martinez-Montemayor M; Dharmawardhane S
    J Biol Chem; 2012 Dec; 287(50):41640-50. PubMed ID: 23095751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equol, an isoflavone metabolite, regulates cancer cell viability and protein synthesis initiation via c-Myc and eIF4G.
    de la Parra C; Borrero-Garcia LD; Cruz-Collazo A; Schneider RJ; Dharmawardhane S
    J Biol Chem; 2015 Mar; 290(10):6047-57. PubMed ID: 25593313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of proto-oncogene BRF2 in breast cancer cells by the dietary soybean isoflavone daidzein.
    Koo J; Cabarcas-Petroski S; Petrie JL; Diette N; White RJ; Schramm L
    BMC Cancer; 2015 Nov; 15():905. PubMed ID: 26573593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.
    Moerke NJ; Aktas H; Chen H; Cantel S; Reibarkh MY; Fahmy A; Gross JD; Degterev A; Yuan J; Chorev M; Halperin JA; Wagner G
    Cell; 2007 Jan; 128(2):257-67. PubMed ID: 17254965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect.
    Rigalli JP; Scholz PN; Tocchetti GN; Ruiz ML; Weiss J
    Eur J Nutr; 2019 Feb; 58(1):139-150. PubMed ID: 29101532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice.
    Ju YH; Fultz J; Allred KF; Doerge DR; Helferich WG
    Carcinogenesis; 2006 Apr; 27(4):856-63. PubMed ID: 16399773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
    Korneeva NL; Song A; Gram H; Edens MA; Rhoads RE
    J Biol Chem; 2016 Feb; 291(7):3455-67. PubMed ID: 26668315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
    Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
    Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
    Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
    Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of the hepatitis A virus IRES requires association between the cap-binding translation initiation factor (eIF4E) and eIF4G.
    Ali IK; McKendrick L; Morley SJ; Jackson RJ
    J Virol; 2001 Sep; 75(17):7854-63. PubMed ID: 11483729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2.
    Magee PJ; Allsopp P; Samaletdin A; Rowland IR
    Eur J Nutr; 2014 Feb; 53(1):345-50. PubMed ID: 23568763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soy isoflavones increase quinone reductase in hepa-1c1c7 cells via estrogen receptor beta and nuclear factor erythroid 2-related factor 2 binding to the antioxidant response element.
    Froyen EB; Steinberg FM
    J Nutr Biochem; 2011 Sep; 22(9):843-8. PubMed ID: 21167702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of eukaryotic translation initiation factor 4E (eIF4E) to eIF4G represses translation of uncapped mRNA.
    Tarun SZ; Sachs AB
    Mol Cell Biol; 1997 Dec; 17(12):6876-86. PubMed ID: 9372919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5'-Cap‒Dependent Translation as a Potent Therapeutic Target for Lethal Human Squamous Cell Carcinoma.
    Srivastava RK; Khan J; Arumugam A; Muzaffar S; Guroji P; Gorbatyuk MS; Elmets CA; Slominski AT; Mukhtar MS; Athar M
    J Invest Dermatol; 2021 Apr; 141(4):742-753.e10. PubMed ID: 32971126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular cap-binding protein, eIF4E, promotes picornavirus genome restructuring and translation.
    Avanzino BC; Fuchs G; Fraser CS
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9611-9616. PubMed ID: 28827335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E.
    Ohlmann T; Rau M; Pain VM; Morley SJ
    EMBO J; 1996 Mar; 15(6):1371-82. PubMed ID: 8635470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol.
    Mathey J; Mardon J; Fokialakis N; Puel C; Kati-Coulibaly S; Mitakou S; Bennetau-Pelissero C; Lamothe V; Davicco MJ; Lebecque P; Horcajada MN; Coxam V
    Osteoporos Int; 2007 May; 18(5):671-9. PubMed ID: 17333448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha.
    Tonetti DA; Zhang Y; Zhao H; Lim SB; Constantinou AI
    Nutr Cancer; 2007; 58(2):222-9. PubMed ID: 17640169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosome loading onto the mRNA cap is driven by conformational coupling between eIF4G and eIF4E.
    Gross JD; Moerke NJ; von der Haar T; Lugovskoy AA; Sachs AB; McCarthy JE; Wagner G
    Cell; 2003 Dec; 115(6):739-50. PubMed ID: 14675538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual and combined soy isoflavones exert differential effects on metastatic cancer progression.
    Martínez-Montemayor MM; Otero-Franqui E; Martinez J; De La Mota-Peynado A; Cubano LA; Dharmawardhane S
    Clin Exp Metastasis; 2010 Oct; 27(7):465-80. PubMed ID: 20517637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.